These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 34956238)
1. Prognostic Risk Model and Tumor Immune Environment Modulation of m5C-Related LncRNAs in Pancreatic Ductal Adenocarcinoma. Yuan H; Liu J; Zhao L; Wu P; Chen G; Chen Q; Shen P; Yang T; Fan S; Xiao B; Jiang K Front Immunol; 2021; 12():800268. PubMed ID: 34956238 [TBL] [Abstract][Full Text] [Related]
2. N6-methylandenosine-related lncRNAs play an important role in the prognosis and immune microenvironment of pancreatic ductal adenocarcinoma. Hu Y; Chen Y Sci Rep; 2021 Sep; 11(1):17844. PubMed ID: 34497315 [TBL] [Abstract][Full Text] [Related]
3. Development of the expression and prognostic significance of m Xu G; Li C; Di Z; Yang Y; Liang L; Yuan Q; Yang Q; Dong X; Xu S; Wu G Cancer Med; 2023 Mar; 12(6):7667-7681. PubMed ID: 36464884 [TBL] [Abstract][Full Text] [Related]
4. The Value of m5C-Related lncRNAs in the Prognostic Assessment and Immunotherapy of Stomach Adenocarcinoma. He C; Zhu X; Kong F; Zhang X; Chai X; Zou C; Zhao D Biomed Res Int; 2022; 2022():2747799. PubMed ID: 35711526 [TBL] [Abstract][Full Text] [Related]
5. The prognostic value and immune landscaps of m6A/m5C-related lncRNAs signature in the low grade glioma. Li R; Chen H; Li C; Qi Y; Zhao K; Wang J; You C; Huang H BMC Bioinformatics; 2023 Jul; 24(1):274. PubMed ID: 37403043 [TBL] [Abstract][Full Text] [Related]
6. Cuproptosis-related lncRNA scoring system to predict the clinical outcome and immune landscape in pancreatic adenocarcinoma. Huang Y; Gong P; Su L; Zhang M Sci Rep; 2023 Nov; 13(1):20870. PubMed ID: 38012210 [TBL] [Abstract][Full Text] [Related]
7. Development and Verification of the Hypoxia- and Immune-Associated Prognostic Signature for Pancreatic Ductal Adenocarcinoma. Chen D; Huang H; Zang L; Gao W; Zhu H; Yu X Front Immunol; 2021; 12():728062. PubMed ID: 34691034 [TBL] [Abstract][Full Text] [Related]
8. Identification and validation of a novel prognosis model based on m5C-related long non-coding RNAs in colorectal cancer. Di Z; Xu G; Ding Z; Li C; Song J; Huang G; Zheng J; Zhang X; Xiong B Cancer Cell Int; 2023 Sep; 23(1):196. PubMed ID: 37670275 [TBL] [Abstract][Full Text] [Related]
9. Five key lncRNAs considered as prognostic targets for predicting pancreatic ductal adenocarcinoma. Song J; Xu Q; Zhang H; Yin X; Zhu C; Zhao K; Zhu J J Cell Biochem; 2018 Jun; 119(6):4559-4569. PubMed ID: 29239017 [TBL] [Abstract][Full Text] [Related]
10. Construction of a m5C-related long non-coding RNA signature for the prognosis of hepatocellular carcinoma. Lu J; Wang H; Cao W; Chen D; He Z; Xu J Hum Cell; 2023 Mar; 36(2):712-724. PubMed ID: 36520346 [TBL] [Abstract][Full Text] [Related]
11. A novel genomic instability-derived lncRNA signature to predict prognosis and immune characteristics of pancreatic ductal adenocarcinoma. Yang H; Zhang W; Ding J; Hu J; Sun Y; Peng W; Chu Y; Xie L; Mei Z; Shao Z; Xiao Y Front Immunol; 2022; 13():970588. PubMed ID: 36148233 [TBL] [Abstract][Full Text] [Related]
12. Identification of m6A/m5C/m1A-associated LncRNAs for prognostic assessment and immunotherapy in pancreatic cancer. Huang Y; Zhang W; Li Q; Wang Z; Yang X Sci Rep; 2023 Mar; 13(1):3661. PubMed ID: 36871072 [TBL] [Abstract][Full Text] [Related]
13. Bioinformatics profiling utilized a nine immune-related long noncoding RNA signature as a prognostic target for pancreatic cancer. Wei C; Liang Q; Li X; Li H; Liu Y; Huang X; Chen X; Guo Y; Li J J Cell Biochem; 2019 Sep; 120(9):14916-14927. PubMed ID: 31016791 [TBL] [Abstract][Full Text] [Related]
14. m6A- and m5C- modified lncRNAs orchestrate the prognosis in cutaneous melanoma and m6A- modified LINC00893 regulates cutaneous melanoma cell metastasis. Shi HZ; Tian CC; Wu MY; Ma L; Sun JF; Chen H Skin Res Technol; 2024 Jul; 30(7):e13842. PubMed ID: 38965799 [TBL] [Abstract][Full Text] [Related]
15. Comprehensive analysis of m5C-Related lncRNAs in the prognosis and immune landscape of hepatocellular carcinoma. Lu Q; Liu L; Wang S; Zhang Q; Li L Front Genet; 2022; 13():990594. PubMed ID: 36339006 [TBL] [Abstract][Full Text] [Related]
16. m5C-Related lncRNAs Predict Overall Survival of Patients and Regulate the Tumor Immune Microenvironment in Lung Adenocarcinoma. Pan J; Huang Z; Xu Y Front Cell Dev Biol; 2021; 9():671821. PubMed ID: 34268304 [TBL] [Abstract][Full Text] [Related]
17. 5-Methylcytosine-Related Long Noncoding RNAs Are Potential Biomarkers to Predict Overall Survival and Regulate Tumor-Immune Environment in Patients with Bladder Cancer. Li Z; Wang S; Chen Y; Huang Y; Li T Dis Markers; 2022; 2022():3117359. PubMed ID: 35371346 [TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNAs expressed in pancreatic ductal adenocarcinoma and lncRNA BC008363 an independent prognostic factor in PDAC. Li J; Liu D; Hua R; Zhang J; Liu W; Huo Y; Cheng Y; Hong J; Sun Y Pancreatology; 2014; 14(5):385-90. PubMed ID: 25200694 [TBL] [Abstract][Full Text] [Related]
19. 5-Methylcytosine Related LncRNAs Reveal Immune Characteristics, Predict Prognosis and Oncology Treatment Outcome in Lower-Grade Gliomas. Zhang J; Wang N; Wu J; Gao X; Zhao H; Liu Z; Yan X; Dong J; Wang F; Ba Y; Ma S; Jin J; Du J; Ji H; Hu S Front Immunol; 2022; 13():844778. PubMed ID: 35309316 [TBL] [Abstract][Full Text] [Related]
20. Novel lactylation-related signature to predict prognosis for pancreatic adenocarcinoma. Peng T; Sun F; Yang JC; Cai MH; Huai MX; Pan JX; Zhang FY; Xu LM World J Gastroenterol; 2024 May; 30(19):2575-2602. PubMed ID: 38817665 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]